1. Home
  2. AAT vs RARE Comparison

AAT vs RARE Comparison

Compare AAT & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

SELL

Current Price

$21.28

Market Cap

1.3B

Sector

Real Estate

ML Signal

SELL

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

SELL

Current Price

$14.52

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AAT
RARE
Founded
1967
2010
Country
United States
United States
Employees
208
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
AAT
RARE
Price
$21.28
$14.52
Analyst Decision
Sell
Buy
Analyst Count
3
21
Target Price
$23.50
★ $26.25
AVG Volume (30 Days)
394.9K
★ 5.0M
Earning Date
10-27-2026
11-03-2026
Dividend Yield
★ 6.34%
N/A
EPS Growth
N/A
★ 7.31
EPS
★ 0.08
N/A
Revenue
$436,204,000.00
★ $673,000,000.00
Revenue This Year
$3.45
$12.87
Revenue Next Year
$2.87
$30.23
P/E Ratio
$268.00
★ N/A
Revenue Growth
N/A
★ 20.13
52 Week Low
$17.72
$12.73
52 Week High
$25.97
$39.89

Technical Indicators

Market Signals
Indicator
AAT
RARE
Relative Strength Index (RSI) 39.80 38.70
Support Level $21.21 $13.95
Resistance Level $21.49 $15.79
Average True Range (ATR) 0.36 0.70
MACD 0.03 0.35
Stochastic Oscillator 25.00 34.85

Price Performance

Historical Comparison
AAT
RARE

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: